1202P - Phase (Ph) II study of MBG453 + spartalizumab in patients (pts) with non-small cell lung cancer (NSCLC) and melanoma pretreated with anti–PD-1/L1 therapy
| Autor: | Mach, N. 1, Curigliano, G. 2, Santoro, A. 3, Kim, D.-W. 4, Tai, D.W.M. 5, Hodi, S. 6, Wilgenhof, S. 7, Doi, T. 8, Longmire, T. 9, Sun, H. 10, Xyrafas, A. 11, Gutzwiller, S. 11, Manenti, L. 10, Lin, C.-C. 12 |
|---|---|
| Zdroj: | In Annals of Oncology October 2019 30 Supplement 5:v491-v492 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|